2 Asian Penny Stocks Under $80M: The Screen Separates a Trap From an Inflection

The cheapest corner of the U.S. stock market is Asian micro-cap ADRs — Chinese and other Asian companies listed in New York with market caps under $80 million and share prices measured in cents and single digits. They are cheap because most of them are genuinely broken. The question worth asking is not "what's the lowest-priced stock?" but "which of these names is cheap because the business is eroding, and which is cheap because the market hasn't caught up to an improving report card?" The factor stack — valuation, growth, profitability, safety, momentum — answers that. Two sub-$80M Chinese ADRs survived a stricter screen, and they sort into opposite buckets.

Kandi Technologies (KNDI): cheap because the engine is broken

Kandi is the value-trap profile. It trades at $0.61, near the bottom of its 52-week range of about $0.56 to $1.40, for a market cap of $60.9 million. On an absolute basis the stock looks like a liquidation bargain: price-to-book is 0.23x, meaning the market prices the whole company at about a quarter of its stated book equity, versus a price-to-book of 1.5x for its closest listed peer, the e-scooter maker Niu Technologies. That is a 1.2x PB gap against a like-for-like Chinese personal-vehicle maker — the kind of discount that looks like a gift until you ask why it exists.

The why is in the operating numbers. Revenue fell 31.5% to $87.4 million in 2025, and the net loss widened to $95.6 million, driven by anti-dumping duty expenses, higher litigation costs, and weak demand for EV and recreational-vehicle products. Return on equity is -30.5% and the operating margin is roughly -65%. Gross margin did improve, to 42.6% from 30.8%, but a company burning money at that rate is repricing its stated book in real time — the $270 million of equity on the balance sheet is not worth book if it keeps going toward that loss. Momentum is broken too: the price sits below both its 50-day and 200-day moving averages at a RSI near 40. AInvest's aggregate signal labels the stock Buy, but its fundamental sub-score of 0.38 is among the weakest readings I see anywhere, which is consistent with the stack.

What this looks like as a portfolio role: this is an asset-recovery and event bet, not a compounding story. The realistic bull case is Kandi's plan to lean into North American UTV sales, but that shows up only if revenue stops shrinking and the loss narrows — neither has happened yet. It earns a small, loss-tolerant position at most, and the trigger to re-rate it is a quarter where revenue stabilizes and the stock reclaims the 200-day average.

111 Inc (YI): cheap while the report card improves

111 is the other kind of cheap — the improving report card, which can be more actionable than any broken cheap name. It trades at $3.59 for a market cap of $31.6 million, and its price-to-sales of 0.02x is a rounding error against the 0.10x of the larger Chinese e-commerce name Baozun. What makes that number real rather than distorted is that 111 is mid-transition: in the first quarter of 2026, net revenue fell 33% year over yearby design, as the company moved to an asset-light model and divested underperforming businesses. Total revenue shrinking while the mix improves is not the same thing as eroding demand.

The mix data is the signal. In that same first quarter, 111 reported gross profit up 75% year over year, promotional-products revenue up 70.2%, and marketplace service revenue up 24.7%, with fulfillment costs falling as a share of revenue. Trailing operating margin is roughly breakeven at -0.2%, a far healthier operating line than Kandi's. The company is also net-cash — enterprise value of $15.8 million sits below the $31.6 million market cap, with about $50 million of cash on the balance sheet — so the transition is not being run off a broken balance sheet, though equity is thin at $27 million and the loss ratio widened in the most recent quarter.

The honest read: this is a higher-beta operational-inflection bet. The gross-margin inflection is real and directionally positive, and it is the metric that matters here — the improving report card the process rewards. But it is not yet a profitable company: net losses are widening while the topline shrinks year over year, so the thesis rests on the margin gains outrunning the revenue declines and reaching net profitability. AInvest's aggregate signal is Buy with a strong fundamental sub-score of 8.59, which is a reasonable cross-check for the inflection thesis.

Where they sit in a portfolio

The mistake would be to lump both into one "cheap Chinese penny stocks" basket and treat them as the same risk. They are opposite trades: KNDI is a broken balance sheet betting on a turnaround, YI is a margin transition betting on the mix working. Because neither is yet profitable, both belong in a small satellite sleeve sized so that a -50% move hurts the portfolio's percentage, not its plan. That is the barbell logic applied to micro-caps: one asset-recovery bet against one operational-inflection bet, each small enough to survive being wrong.

The structural overhang argues for the same restraint. In September 2025 Nasdaq proposed — and in December the SEC approved — tighter continued-listing standards aimed specifically at small Chinese companies, after years of scrutiny over manipulation and fraud in that corner. That is a real delisting and compliance risk that no factor grade captures. Cheapness is not the opportunity in this market; the factor stack is, and it says to own these names small, expect the V-shaped volatility, and let a quarter of stabilized or improved fundamentals — not the share price — decide whether either earns more room in the portfolio.